Obesity As a Risk Factor for Malignant Melanoma and Non-melanoma Skin Cancer

Overview

Journal Rev Endocr Metab Disord

Publisher Springer

Specialty Endocrinology

Date 2016 Nov 11

PMID 27832418

Citations 30

Authors

K Karimi

T H Lindgren

C A Koch

Robert T Brodell

Affiliations

Soon will be listed here.

Abstract

The dramatic increases in incidence of both obesity and many cancers including skin cancer emphasize the need to better understand the pathophysiology of both conditions and their connections. Melanoma is considered the fastest growing cancer and rates of non-melanoma skin cancer have also increased over the last decade. The molecular mechanisms underlying the association between obesity and skin cancer are not clearly understood but emerging evidence points to changes in the tumor microenvironment including aberrant cell signaling and genomic instability in the chronic inflammatory state many obese individuals experience. This article reviews the literature linking obesity to melanoma and non-melanoma skin cancer.

Citing Articles

A genetically informed study reveals modifiable pathways in skin cancer.

Qian H, Gong R, Li Y, Zhu J, Wang L J Transl Med. 2024; 22(1):916.

PMID: 39379979 PMC: 11463105. DOI: 10.1186/s12967-024-05719-1.

A recent update on the connection between dietary phytochemicals and skin cancer: emerging understanding of the molecular mechanism.

Singh H, Mishra A, Mohanto S, Kumar A, Mishra A, Amin R Ann Med Surg (Lond). 2024; 86(10):5877-5913.

PMID: 39359831 PMC: 11444613. DOI: 10.1097/MS9.0000000000002392.

New Insights into the Link Between Melanoma and Obesity.

Neagu M, Dobre E Adv Exp Med Biol. 2024; 1460:851-867.

PMID: 39287874 DOI: 10.1007/978-3-031-63657-8_28.

Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling.

Slominski R, Kim T, Janjetovic Z, Brozyna A, Podgorska E, Dixon K Cancers (Basel). 2024; 16(12).

PMID: 38927967 PMC: 11201527. DOI: 10.3390/cancers16122262.

A registration trend in eyelid skin cancers and associated risk factors in Iran, 2005-2016.

Safi S, Ahmadzade M, Karimi S, Akbari M, Rouientan H, Abolhosseini M BMC Cancer. 2023; 23(1):924.

PMID: 37777736 PMC: 10543867. DOI: 10.1186/s12885-023-11414-z.

References

Sadagurski M, Yakar S, Weingarten G, Holzenberger M, Rhodes C, Breitkreutz D . Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol Cell Biol. 2006; 26(7):2675-87. PMC: 1430337. DOI: 10.1128/MCB.26.7.2675-2687.2006. View

Ward E, Burnett C, Ruder A . Industries and cancer. Cancer Causes Control. 1997; 8(3):356-70. DOI: 10.1023/a:1018405321141. View

Arnardottir E, Maislin G, Jackson N, Schwab R, Benediktsdottir B, Teff K . The role of obesity, different fat compartments and sleep apnea severity in circulating leptin levels: the Icelandic Sleep Apnea Cohort study. Int J Obes (Lond). 2012; 37(6):835-42. PMC: 3537909. DOI: 10.1038/ijo.2012.138. View

Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B . Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A. 2004; 101(8):2476-81. PMC: 356975. DOI: 10.1073/pnas.0308671100. View

Shoag J, Haq R, Zhang M, Liu L, Rowe G, Jiang A . PGC-1 coactivators regulate MITF and the tanning response. Mol Cell. 2012; 49(1):145-57. PMC: 3753666. DOI: 10.1016/j.molcel.2012.10.027. View

De Coster S, van Larebeke N . Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health. 2012; 2012:713696. PMC: 3443608. DOI: 10.1155/2012/713696. View

Leroy P, Dessolin S, Villageois P, Moon B, Friedman J, Ailhaud G . Expression of ob gene in adipose cells. Regulation by insulin. J Biol Chem. 1996; 271(5):2365-8. DOI: 10.1074/jbc.271.5.2365. View

Ozcan L, Ergin A, Lu A, Chung J, Sarkar S, Nie D . Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009; 9(1):35-51. DOI: 10.1016/j.cmet.2008.12.004. View

McDonald E, Freedman D, Alexander B, Doody M, Tucker M, Linet M . Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohort. Cancer Epidemiol Biomarkers Prev. 2014; 23(8):1539-45. PMC: 4119543. DOI: 10.1158/1055-9965.EPI-14-0251. View

10.

Pollitt R, Clarke C, Shema S, Swetter S . California Medicaid enrollment and melanoma stage at diagnosis: a population-based study. Am J Prev Med. 2008; 35(1):7-13. PMC: 4350993. DOI: 10.1016/j.amepre.2008.03.026. View

11.

McMurphy T, Xiao R, Magee D, Slater A, Zabeau L, Tavernier J . The anti-tumor activity of a neutralizing nanobody targeting leptin receptor in a mouse model of melanoma. PLoS One. 2014; 9(2):e89895. PMC: 3938505. DOI: 10.1371/journal.pone.0089895. View

12.

Millington G . Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol. 2006; 31(3):407-12. DOI: 10.1111/j.1365-2230.2006.02128.x. View

13.

Veierod M, Thelle D, Laake P . Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer. 1997; 71(4):600-4. DOI: 10.1002/(sici)1097-0215(19970516)71:4<600::aid-ijc15>3.0.co;2-f. View

14.

Sharma S, Katiyar S . Leptin deficiency-induced obesity exacerbates ultraviolet B radiation-induced cyclooxygenase-2 expression and cell survival signals in ultraviolet B-irradiated mouse skin. Toxicol Appl Pharmacol. 2010; 244(3):328-35. DOI: 10.1016/j.taap.2010.01.010. View

15.

Kang J, Lee Y, Yu B, Yang B, Cho K, Yoon D . Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res. 2005; 28(11):1263-9. DOI: 10.1007/BF02978210. View

16.

Gallagher E, Fierz Y, Ferguson R, LeRoith D . The pathway from diabetes and obesity to cancer, on the route to targeted therapy. Endocr Pract. 2010; 16(5):864-73. DOI: 10.4158/EP10098.RA. View

17.

Wang H, Ye J . Regulation of energy balance by inflammation: common theme in physiology and pathology. Rev Endocr Metab Disord. 2014; 16(1):47-54. PMC: 4346537. DOI: 10.1007/s11154-014-9306-8. View

18.

Praestegaard C, Kjaer S, Christensen J, Tjonneland A, Halkjaer J, Jensen A . Obesity and risks for malignant melanoma and non-melanoma skin cancer: results from a large Danish prospective cohort study. J Invest Dermatol. 2014; 135(3):901-904. DOI: 10.1038/jid.2014.438. View

19.

Frisancho A, Wainwright R, Way A . Heritability and components of phenotypic expression in skin reflectance of Mestizos from the Peruvian lowlands. Am J Phys Anthropol. 1981; 55(2):203-8. DOI: 10.1002/ajpa.1330550207. View

20.

Dieudonne M, Pecquery R, Leneveu M, Giudicelli Y . Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine. 2002; 18(2):179-84. DOI: 10.1385/ENDO:18:2:179. View